Life Sciences

Akoya Biosciences, a Marlborough firm analyzing tissues for therapy research, announced on Tuesday it had closed its initial public offering with gross proceeds reaching $151.3 million. 

Waters Corp., a life sciences company based in Milford, announced two new senior vice presidents and the organization’s new chief financial officer on Wednesday. 

Marlborough insulin delivery company CeQur announced Tuesday it had raised $115 million in equity financing.

Holliston biotechnology company Biostage Inc. cut its yearly losses by $3.4 million through reductions in research & development and administrative expenses.

Framingham life science consulting firm Alira Health announced Tuesday it has closed $35 million in equity financing.

Arranta Bio, a microbiome contract development and manufacturing organization, is planning a $150-million facility in Boxborough to drastically increase its capacity beyond its sites in Watertown and Florida.

The Worcester life sciences incubator Massachusetts Biomedical Initiatives has won a $252,000 federal grant to help spur regional economic development and biomedical entrepreneurship.

Southborough life sciences firm Veristat announced on Thursday that WindRose Health Investors now holds majority ownership of the company.

Life sciences analytics technology firm SCIEX has announced the appointment of Joe Fox as the Framingham-based company's new president.

Marlborough early stage drugmaker Phio Pharmaceuticals, has ended the year in a strong position, with enough funding to continue its current programs for the next two years, the company announced last week.